Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Sin1/MAPKAP1 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody has been used in 1 publication
Supplier: Novus Biologicals NBP18956925UL
Description
Sin1/MAPKAP1 Polyclonal specifically detects Sin1/MAPKAP1 in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
Sin1/MAPKAP1 | |
Polyclonal | |
Western Blot 0.4 ug/ml, Immunohistochemistry, Immunohistochemistry-Paraffin 1:20 - 1:50 | |
JC310, MEKK2-interacting protein 1, MGC2745, MIP1SIN1SIN1b, Mitogen-activated protein kinase 2-associated protein 1, mitogen-activated protein kinase associated protein 1, mSIN1, ras inhibitor MGC2745, SAPK-interacting protein 1, SIN1g, stress-activated map kinase interacting protein 1, Stress-activated map kinase-interacting protein 1, stress-activated protein kinase-interacting 1, target of rapamycin complex 2 subunit MAPKAP1, TORC2 subunit MAPKAP1 | |
Rabbit | |
Affinity Purified | |
RUO | |
Primary | |
Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin) | |
Unconjugated | |
PBS (pH 7.2) and 40% Glycerol with 0.02% Sodium Azide | |
MAPKAP1 | |
This antibody was developed against Recombinant Protein corresponding to amino acids:NPFNEYSKFDGKGHVGTTATKKIDVYLPLHSSQDRLLPMTVVTMASARVQDLIGLICWQYTSEGREPKLNDNVSAYCLHIAEDDGEVDTDFPPLDSNEPIHKFGFSTLALVEKYSSPGLTSKESLFVRINAAHGFSLIQVDNTKVTMKE | |
25 μL | |
Autophagy, Cancer, mTOR Pathway, Protein Kinase | |
79109 | |
Human, Mouse, Rat | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction